Efficacy and Safety of Targeted Therapies in #VEXAS Syndrome: Retrospective Study from the French VEXAS Group 🙂
#ACR23 late breaking poster – the figure says it all
https://t.co/qahDDPLois https://t.co/ueb4aG8t77